Thrivent Financial for Lutherans Sells 3,039 Shares of HCA Healthcare, Inc. $HCA

Thrivent Financial for Lutherans cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 29.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,151 shares of the company’s stock after selling 3,039 shares during the quarter. Thrivent Financial for Lutherans’ holdings in HCA Healthcare were worth $2,740,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of HCA. ORG Partners LLC increased its stake in HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after purchasing an additional 31 shares in the last quarter. Glenview Trust co boosted its holdings in HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares in the last quarter. Sivia Capital Partners LLC raised its position in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Claret Asset Management Corp grew its position in HCA Healthcare by 5.9% in the 2nd quarter. Claret Asset Management Corp now owns 614 shares of the company’s stock valued at $235,000 after purchasing an additional 34 shares during the period. Finally, Facet Wealth Inc. lifted its stake in shares of HCA Healthcare by 6.1% in the second quarter. Facet Wealth Inc. now owns 643 shares of the company’s stock valued at $228,000 after buying an additional 37 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. TD Cowen raised their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Mizuho upped their price target on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Royal Bank Of Canada raised their price target on shares of HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a research note on Thursday, November 13th. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $479.00.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 0.2%

HCA opened at $471.94 on Tuesday. The company’s 50-day moving average price is $471.35 and its two-hundred day moving average price is $417.92. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $520.00. The stock has a market cap of $107.69 billion, a price-to-earnings ratio of 18.24, a PEG ratio of 1.40 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 11.13%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.